Gracell Biotechnologies to Present Clinical Data on BCMA/CD1

/PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to...

Related Keywords

Suzhou , Jiangsu , China , United States , Shanghai , Germany , American , Wendy Li , Marvin Tang , Jessica Laub , Stephanie Carrington , Exchange Commission , Fierce Life Sciences Innovation , Nasdaq , Gracell Biotechnologies Inc , American Cancer Society , American Society Of Clinical Oncology , European Hematology Association , Gracell Biotechnologies , Hematology Association , Annual Meeting , Clinical Oncology , Chief Medical , Targeted Donor Derived Allogeneic , Antigen Receptort Cells , B Cell Acute Lymphoblastic Leukemia , Investigational New Drug , Biotech Innovation , Life Sciences Innovation Awards , American Cancer , Private Securities Litigation Reform Act ,